@ Tryton Medical raises $24 million | SEBIO

Tryton Medical raises $24 million

Posted by on Jan 7, 2013

DURHAM, NC – Tryton Medical Inc. has closed on $24 million in financing.Tryton develops medical stents and the financing should see the company through the U.S. approval of its latest product, the TrytonSide Branch Stent, CEO Shaw McCarthy says.

“The funds will be used to support the company’s U.S. Food & Drug Administration submission this year, to expand the company’s platform portfolio with a new stent system designed to address left main disease, and to accelerate access into critical global markets, specifically in Asia.”

The new Branch Stent addresses what’s called “bifurcated lesions,” which can develop in coronary artery disease patients.

Investors participating in the round included PTV Sciences, RiverVest Venture Partners, Spray Venture Partners and the 3×5 Special Opportunity Fund, all existing investors.



Leave a Reply